Cytochrome P-450 CYP2C19 Inhibitors
Showing 1 - 25 of >10,000
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
Drug Intolerance, Cytochrome P450 CYP2D6 Enzyme Deficiency, Drug Effect Trial in Geneva (Pupillometry)
Terminated
- Drug Intolerance
- +2 more
- Pupillometry
-
Geneva, SwitzerlandGeneva University Hospitals, Geneva, Switzerland
Nov 24, 2022
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
Healthy Trial in Geneva (Dextromethorphan 5 MG, Paroxetine 10Mg Tablet, Paroxetine 20Mg Tablet)
Completed
- Healthy
- Dextromethorphan 5 MG
- +2 more
-
Geneva, SwitzerlandHUG
Jan 3, 2022
Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)
Not yet recruiting
- Coronary Artery Disease
- Platelet Reactivity
- CYP2C19 genotype guided P2Y12 monotherapy
- Clopidogrel
- (no location specified)
Mar 7, 2023
Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant Trial in Bauru
Completed
- Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
- Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
-
Bauru, São Paulo, BrazilBauru School of Dentistry/USP
Nov 2, 2020
Cytochrome P450 Abnormalities in Patients With Delirium.
Completed
- Delirium, Cytochrome P-450 Enzyme System
- Cytochrome P450 test
-
Park Ridge, IllinoisDavid Ronin
Jul 14, 2020
Based on CYP2C19 Genotype in Ischemic Stroke
Active, not recruiting
- Acute Ischemic Stroke
- General principles of care and judgement of researcher
-
Yongin-si, Gyeonggi-do, Korea, Republic of
- +36 more
Oct 23, 2022
Aspergillosis Invasive, Fungal Infection Trial in Toronto (Voriconazole genotype-specific dosing, Standard of Care)
Completed
- Aspergillosis Invasive
- Fungal Infection
- Voriconazole genotype-specific dosing
- Standard of Care
-
Toronto, Ontario, Canada
- +1 more
Nov 2, 2020
Healthy Trial in Dallas (Lu AG06466, Midazolam, Metoprolol)
Completed
- Healthy
- Lu AG06466
- +3 more
-
Dallas, TexasCovance Dallas CRU
Apr 19, 2021
Drug-Interactions Trial in Baltimore (Inje cocktail, THC Cannabis extract, THC/CBD Cannabis Extract)
Active, not recruiting
- Drug-Interactions
- Inje cocktail
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Mar 21, 2022
Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)
Active, not recruiting
- Metastatic Castration-resistant Prostate Cancer
- Acapatamab
- +3 more
-
Birmingham, Alabama
- +13 more
Jun 20, 2022
Kidney Rejection Transplant Trial in Poznan (Assessment of the drug concentration in the blood)
Active, not recruiting
- Kidney Rejection Transplant
- Assessment of the drug concentration in the blood
-
Poznan, PolandUniversity Clinical Hospital in Poznan of the Poznan University
Jan 19, 2023
Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)
Recruiting
- Angina, Stable
- +3 more
- CYP2C19 genotype testing
-
Beijing, Beijing, China
- +11 more
Nov 4, 2021
Healthy Trial in Rennes (Drug Cocktail, Foliglurax, midazolam iv)
Completed
- Healthy
- Drug Cocktail
- +2 more
-
Rennes, FranceBiotrial
Apr 22, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
-
Cooperstown, New York
- +10 more
Dec 11, 2022
Healthy Participants Trial in Salt Lake City (DC-806, Midazolam, Repaglinide)
Not yet recruiting
- Healthy Participants
- DC-806
- +4 more
-
Salt Lake City, UtahICON Phase 1 Clinic
Oct 16, 2023
Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation Trial in Searcy (Pharmacogenetic testing)
Completed
- Adverse Drug Events
- +12 more
- Pharmacogenetic testing
-
Searcy, ArkansasWhite County Medical Center Home Health
Sep 18, 2019
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022